Friday, July 1, 2016

BioLight reports positive TeaRx test results for DES

BioLight reports positive TeaRx test results for DES

January 7, 2016 by · Leave a Comment 

Tweet BioLight Israeli Life Sciences Investments (OTCQX: BLGTY; TASE: BOLT) has completed a second successful U.S. clinical study to assess the effectiveness of its TeaRx multi-assay test in evaluating tears’ components of healthy subjects as well as of patients suffering from dry eye syndrome (DES). The study, conducted by development partner Ora Inc., enrolled 74 […]

Email Newsletters with Constant Contact
Google+